Patent Application. 10.7.1 Employees agree to disclose the existence of any patent applications to OC prior to the date of the application and shall affirm in writing at that time whether or not the invention, improvement, design or development has been made and developed with the use of OC funds, personnel or equipment. Within one (1) month of receipt of the statement of the employee(s), OC may challenge in writing the assertion of the employee(s) in regard to the circumstances of the origin of the invention, improvement, design or development, in which case the matter shall be settled by arbitration as detailed in Article 36 (
Patent Application. 13.1. The Collaborator may file any Patent Application with the prior written consent of JTC (such consent not to be unreasonably withheld) on the following terms and conditions:
13.1.1. the Collaborator shall take the lead in the preparation, filing, prosecution and maintenance of the Patent Application in accordance with the terms of this Agreement (the “Lead Party”); and
13.1.2. at the time of granting its consent, JTC shall be entitled to elect whether JTC wishes to be a co-applicant of the Patent Application. For clarity, the Parties agree that JTC is entitled to withhold consent for filing of any Patent Application should JTC determine that:
a) the filing of the Patent Application prejudices or is contrary to national interest such as national security; or
b) the filing of the Patent Application prejudices or is contrary to public interest, for instance, where the Foreground IP and/or patentable inventions is necessary for carrying out regulatory responsibilities and should not be the monopoly of any one company.
13.2. In the event that JTC elects to be a co-applicant of the Patent Application, the following terms and conditions shall apply:
13.2.1. the Patent Application shall be filed in the joint names of JTC and the Collaborator as joint owners of equal undivided shares thereof;
13.2.2. the Lead Party shall further ensure compliance with all applicable Singapore patent laws and regulations when filing the Patent Application, including obtaining any necessary national security clearances from the Intellectual Property Office of Singapore prior to any foreign filings of the Patent Application.
13.2.3. the Lead Party shall provide JTC with:
13.2.3.1 a copy of any draft of such Patent Application sufficiently prior to filing to permit JTC reasonable opportunity to review and make comments thereon
13.2.3.2 copies of all substantive communications received from patent offices with respect to such filings; and
13.2.3.3 copies of all grants or certificates of registration of any such Patent Application;
13.2.4. the Parties agree to give each other reasonable assistance in the preparation, filing, prosecution and maintenance of any such Patent Application filed and shall cause to be executed all assignments and other instruments and documents as may be necessary or appropriate;
13.2.5. unless otherwise agreed, all IP Expenses shall be shared by the Parties equally; and
13.2.6. the Lead Party shall not abandon the prosecution or maintenance of any such Pat...
Patent Application. ERF represents that with respect to the ERF Technology, including any new products, it will use its best efforts to file patent applications as soon as reasonably practical.
Patent Application. Lessee may, at its expense, seek to patent in Lessor’s name any and all unpatented mining claims which are pert of the Property. Lessor pledges full cooperation to Lessee in executing any documents necessary to accomplish patenting if so desired by Lessee. If Lessee begins patent proceedings and Lessee desires to discontinue them, or if this Agreement is terminated while patent proceedings are pending, Lessee shall have no further obligation with respect thereto, except to pay any unpaid expenses accrued in such proceedings prior to its request to discontinue, or prior to termination, whichever occurs first. If the patent application results in cancellation of any unpatented claims, Lessee shall not be liable for any claims, losses or damages resulting from such cancellation. Lessor appoints Lessee as Lessor’s lawful Attorney In Fact for the purpose of patent applications. All patents shall be part of the Property and the parties will promptly, after issuance of each patent, execute and deliver an addendum to this Agreement and a memorandum of this Agreement to such effect.
Patent Application. 2.1 The Parties agree that any inventions which fall under the definitions within the Research Agreement of Joint Arising IP or Jointly Developed Arising IP and which arise pursuant to the Research Agreement shall be owned jointly by those Parties developing the same as tenants in common in equal shares, save that in the case of any share which would otherwise be owned by Oxford, such share shall be owned by Oxford or Isis as appropriate.
2.2 Any invention which any of the Parties shall determine shall be of commercial value shall be recorded in writing and shall be scheduled to this Agreement in the form set out in the Annex.
2.3 The Parties agree that CDT will, in consultation with Isis, Oxford and St Xxxxxxx, apply for the Patents in the joint names of the owners of the relevant Inventions, and shall prosecute and maintain the Patents seeking the broadest monopoly which is reasonable and consistent with validity.
2.4 CDT shall diligently pursue the grant of Patents in respect of each of the Inventions and Isis, Oxford and St Xxxxxxx, at the reasonable request of CDT, agree to execute all such documents and do all such acts and things as may be necessary for the purpose of clause 2.3.
2.5 All fees and expenses relating to the filing and prosecution of the Patents shall be borne by CDT and CDT shall reimburse all disbursements paid by Isis, Oxford and St Xxxxxxx in discharging their obligations under clause 2.4.
2.6 If, at any time, any of Isis, Oxford, St Xxxxxxx or CDT indicates to the others by notice in writing that it no longer desires to apply for, pursue or maintain any of the Patent(s) and within one month of such notice one or more of the other parties notifies such party of its/their willingness to take over the rights of such party in the relevant Patent(s) (or Inventions relating thereto), the first mentioned party shall assign to the other(s) the relevant Patent(s) (or Inventions relating thereto) without any payment by such party. The first mentioned party shall, at the expiration of one month from the date of its notice:
2.6.1 cease to be liable to bear the fees and expenses referred to in clause 2.5 (if any) relating to the relevant Patent (or Invention relating thereto);
2.6.2 cease to be eligible to receive any proportion of Gross Sales or Gross Receipts in accordance with clause 5 relating to the relevant Patent (or Invention relating thereto); and
2.6.3 cease to have any control over the exploitation of the relevant Patent (or Inventio...
Patent Application. 9.7.1 Employees agree to disclose the existence of any patent applications to OUC prior to the date of the application and shall affirm in writing at that time whether or not the invention, improvement, design or development has been made and developed with the use of OUC funds, personnel or equipment. Within one (1) month of receipt of the statement of the employee(s), OUC may challenge in writing the assertion of the employee(s) in regard to the circumstances of the origin of the invention, improvement, design or development, in which case the matter shall be settled by arbitration as detailed in Article 40 (
Patent Application. Employee agrees, at the request, ------------------ and at the expense, of the Company, to make application in due form for United States letters patent and foreign letters patent on the inventions, discoveries, improvements, apparatus, processes, compounds and formulae which may be directly or indirectly useful in or relate to the Company's electro-optical polymer technology and to assign to the Company all right, title and interest in the inventions, discoveries, improvements, apparatus, processes, compounds, formulae, and patent applications therefor or patents thereon which may be directly or indirectly useful in or relate to, the Company's electro-optical polymer technology, and to execute at any and all times, any and all instruments and do any and all acts necessary or which the Company may deem desirable in connection with any such application for letters patent or in order to establish and perfect in the Company the entire right, title and interest to the inventions, discoveries, improvements, apparatus, processes, compounds, formulae, patent applications or patents which may be directly or indirectly useful in or relate to, the Company's electro-optical polymer technology, and also to execute any instruments necessary or which the Company may deem desirable in connection with any continuations, renewals or reissues or in the conduct of any proceedings or litigation.
Patent Application. I hereby assign and agree to assign to the Company, all my right, title and interest in and to all inventions, discoveries, improvements, ideas, computer or other apparatus programs and related documentation, and other works of authorship (hereinafter each and collectively designated "Intellectual Property"), whether or not capable of registration under applicable patent or copyright laws or susceptible to other forms of protection, which during the period of my employment by the Company I may make or create, solely or jointly with others, in whole or in part, either:
Patent Application. UEC (i) may file patent application at its own discretion and expense, including expenses to be paid to registration organs such as the Patent Office, and external patent attorneys who are not affiliated with either party, etc., for acquisition of the patent right in any country, or (ii) shall do so at the request of the Sponsor at the Sponsor’s expense at a country or countries requested by Sponsor. When UEC has filed patent application in any country in accordance with (i) and/or (ii) above, UEC shall promptly notify to the Sponsor in writing and deliver copies of the relevant documents. In case of (ii) above, the Sponsor shall also bear expenses to maintain the registration.
Patent Application. Animals Transgenic for a Tetracycline-Regulated Transcriptional Inhibitor, by Bujard and Gossxx. XXI-009C6CN; BBC-009J.
